Bnp Paribas Arbitrage, Sa reports 9.58% decrease in ownership of HVE / Innoviva, Inc.

Innoviva, Inc.

DE ˙ DB ˙ US45781M1018

19,20 € ↑0,70 (3,78%)

2026-06-04
DEL PRIS

Security	DE:HVE / Innoviva, Inc.
Institution	Bnp Paribas Arbitrage, Sa
Latest Disclosed Ownership	76,514 shares
Latest Disclosed Value	$ 1,782,776

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 76,514 shares of Innoviva, Inc. (DE:HVE) valued at $1,530,280 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 84,618 shares of Innoviva, Inc.. This represents a change in shares of -9.58% during the quarter. The current value of the position is $1,469,069 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-12	2026-03-31	13F	Innoviva	Equity	45781M101	76,514	-8,104	-9.58	1,783	5.38	0.0001
2026-02-10	2025-12-31	13F	Innoviva	Equity	45781M101	84,618	-71,077	-45.65	1,692	-40.48	0.0008
2025-11-13	2025-09-30	13F	Innoviva	Equity	45781M101	155,695	-114,019	-42.27	2,841	-47.56	0.0015
2025-08-14	2025-06-30	13F	Innoviva	Equity	45781M101	269,714	134,588	99.60	5,419	121.23	0.0031
2025-05-14	2025-03-31	13F	Innoviva	Equity	45781M101	135,126	-38,002	-21.95	2,450	-18.45	0.0014
2025-02-14	2024-12-31	13F	Innoviva	Equity	45781M101	173,128	43,233	33.28	3,004	19.74	0.0017
2024-11-13	2024-09-30	13F	Innoviva	Equity	45781M101	129,895	110,622	573.97	2,508	693.67	0.0017
2024-08-13	2024-06-30	13F	Innoviva	Equity	45781M101	19,273	-54,299	-73.80	316	-71.81	0.0003
2024-05-01	2024-03-31	13F	Innoviva	Equity	45781M101	73,572	15,593	26.89	1,121	20.67	0.0010
2024-02-14	2023-12-31	13F/A-2	Innoviva	Equity	45781M101	57,979	26,980	87.04	930	131.09	0.0011
2024-02-07	2023-12-31	13F/A-1	Innoviva	Equity	45781M101	57,979	26,980		930		0.0001
2024-02-07	2023-12-31	13F	Innoviva	Equity	45781M101	57,979			930
2023-11-14	2023-09-30	13F	Innoviva	Equity	45781M101	30,999	13,868	80.95	403	84.40	0.0005
2023-08-09	2023-06-30	13F	Innoviva	Equity	45781M101	17,131	-1,854	-9.77	218	2.35	0.0003
2023-05-12	2023-03-31	13F	INNOVIVA	EQUITY	45781M101	18,985	13,878	271.74	214	217.91	0.0003
2023-02-14	2022-12-31	13F	Innoviva	Equity	45781M101	5,107	-10,203	-66.64	68	-23.86	0.0001
2022-11-16	2022-09-30	13F/A-1	Theseus Pharmaceuticals	Equity	88369M101	15,310	-111,291	-87.91	89	-95.29	0.0001
2022-11-16	2022-09-30	13F/A-1	Innoviva	Equity	45781M101	133,546	6,945		1,550		0.0025
2022-11-15	2022-09-30	13F	Theseus Pharmaceuticals	Equity	88369M101	15,310	15,310		89		0.0000
2022-11-15	2022-09-30	13F	Innoviva	Equity	45781M101	133,546	6,945		1,550		0.0004
2022-08-12	2022-06-30	13F	Innoviva	Equity	45781M101	126,601	-191,112	-60.15	1,869	-69.61	0.0029
2022-05-18	2022-03-31	13F/A-1	Innoviva	Equity	45781M101	317,713	285,135	875.24	6,148	995.72	0.0083
2022-02-09	2021-12-31	13F	INNOVIVA	EQUITY	45781M101	32,578	-28,458	-46.62	562	-44.95	0.0008
2021-11-16	2021-09-30	13F/A-1	INNOVIVA	EQUITY	45781M101	61,036	33,305	120.10	1,020	174.66	0.0014
2021-11-12	2021-09-30	13F	INNOVIVA	EQUITY	45781M101	119,379	91,648		1,248		0.0000
2021-08-10	2021-06-30	13F	INNOVIVA	EQUITY	45781M101	27,731	14,989	117.63	372	144.08	0.0005
2021-05-07	2021-03-31	13F	INNOVIVA	EQUITY	45781M101	12,742	-96,886	-88.38	152	-88.81	0.0002
2021-02-10	2020-12-31	13F	INNOVIVA	EQUITY	45781M101	109,628	-9,751	-8.17	1,358	8.90	0.0025
2020-10-30	2020-09-30	13F	INNOVIVA	EQUITY	45781M101	119,379	113,977	2,109.90	1,248	1,562.67	0.0018
2020-08-06	2020-06-30	13F	INNOVIVA	EQUITY	45781M101	5,402	-226,444	-97.67	76	-97.25	0.0001
2020-05-13	2020-03-31	13F	INNOVIVA	EQUITY	45781M101	231,846	116,458	100.93	2,727	66.93	0.0056
2020-02-12	2019-12-31	13F	INNOVIVA	EQUITY	45781M101	115,388	103,160	843.64	1,634	1,175.78	0.0030
2019-11-07	2019-09-30	13F	INNOVIVA	EQUITY	45781M101	12,228	3,005	32.58	129	-4.48	0.0002
2019-07-30	2019-06-30	13F	INNOVIVA	EQUITY	45781M101	9,223	-6,667	-41.96	134	-39.64	0.0003
2019-04-25	2019-03-31	13F	INNOVIVA	EQUITY	45781M101	15,890	14,326	915.98	223	722.22	0.0005
2019-02-12	2018-12-31	13F	INNOVIVA	EQUITY	45781M101	1,564	-2,528	-61.78	27	-56.45	0.0001
2018-11-07	2018-09-30	13F	INNOVIVA	EQUITY	45781M101	4,092	-3,618	-46.93	62	-41.51	0.0001
2018-07-25	2018-06-30	13F	INNOVIVA	EQUITY	45781M101	7,710	-16,107	-67.63	106	-73.30	0.0002
2018-05-11	2018-03-31	13F	INNOVIVA	EQUITY	45781M101	23,817	-7,727	-24.50	397	-11.19	0.0007
2018-03-05	2017-12-31	13F/A-1	INNOVIVA	EQUITY	45781M101	31,544	-7,577	-19.37	448	-19.02	0.0008
2018-02-01	2017-12-31	13F	INNOVIVA	EQUITY	45781M101	31,544	-7,577		448
2017-11-03	2017-09-30	13F	INNOVIVA	STOCK	45781M101	39,121	14,931	61.72	552	78.64	0.0013
2017-08-03	2017-06-30	13F	INNOVIVA	STOCK	45781M101	24,190	8,206	51.34	310	39.82	0.0009
2017-05-03	2017-03-31	13F	INNOVIVA	STOCK	45781M101	15,984	1,656	11.56	221	44.44	0.0006
2017-02-14	2016-12-31	13F	INNOVIVA	STOCK	45781M101	14,328	7,658	114.81	153	109.59	0.0007
2016-10-05	2016-09-30	13F	* INNOVIVA INC COM	STOCK	45781M101	6,670	3,538	112.96	73	128.13	0.0003
2016-07-06	2016-06-30	13F	* INNOVIVA INC COM	STOCK	45781M101	3,132	3,132		33		0.0001
2016-04-22	2016-03-31	13F	* THERAVANCE INC COM	STOCK	88338T104	0	-8,314	-100.00	0	-100.00
2016-02-10	2015-12-31	13F	* THERAVANCE INC COM	STOCK	88338T104	8,314	-10,064	-54.76	88	-33.59	0.0004
2015-11-13	2015-09-30	13F	* THERAVANCE INC COM	STOCK	88338T104	18,378	11,294	159.43	132	2.34	0.0003
2015-08-14	2015-06-30	13F	THERAVANCE INC COM	STOCK	88338T104	7,084	5,133	263.10	128	326.67	0.0004
2015-05-15	2015-03-31	13F	* THERAVANCE INC COM	STOCK	88338T104	1,951	1,951	0.00	31		0.0001
2015-02-11	2014-12-31	13F	* THERAVANCE INC COM	STOCK	88338T104	0	-4,940	-100.00	0	-100.00
2014-11-12	2014-09-30	13F	* THERAVANCE INC COM	STOCK	88338T104	4,940			84	-99.99	0.0001
2014-04-02	2013-12-31	13F/A-1	THERAVANCE	BOND	88338T104				1,163,040	43.04	0.8480
2014-02-12	2013-12-31	13F	THERAVANCE	BOND	88338T104				1,163,040
2013-11-13	2013-09-30	13F	THERAVANCE	BOND	88338T104	5,000,000	0	0.00	813,100	5.52	0.5914
2013-08-13	2013-06-30	13F	THERAVANCE	BOND	88338T104	5,000,000	5,000,000		770,600		0.5449

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.